Combination therapy in rheumatoid arthritis: Updated systematic review

British Journal of Rheumatology

Volumn 37, Issue 6, 1998, Pages 612-619

  Verhoeven, A C ^a   Boers, M ^b   Tugwell, P ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Combined treatment; Dmards; Glucocorticoids; Rheumatoid arthritis; Systematic review

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; GLUCOCORTICOID; HYDROXYCHLOROQUINE; METHOTREXATE; SALAZOSULFAPYRIDINE;

ARTICLE; CLINICAL RESEARCH; DRUG EFFICACY; DRUG INTERACTION; DRUG TOXICITY; HUMAN; METHODOLOGY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT PLANNING;

EID: 0031949858     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.6.612     Document Type: Article

References (43)

1. van der Heide A, Jacobs JWG, Bijlsma JWJ et al. The effectiveness of early treatment with 'second-line' anti- rheumatic drugs; a randomized, controlled trial. Ann Intern Med 1996;124:699-707.
2. Boers M, Ramsden M. Long-acting drug combinations in rheumatoid arthritis: a formal overview. J Rheumatol 1991;18:316-24.
3. Tugwell P, Boers M. Long-acting drug combinations in rheumatoid arthritis. Updated overview. In: Wolfe F, Pincus T, eds. Rheumatoid arthritis: pathogenesis, assessment, outcome and treatment. New York: Marcel Dekker, 1994:357-71.
4. Sackett D, Haynes, Tugwell P. Deciding on the best therapy. In: Clinical epidemiology. A basic science for clinical medicine. Boston: Little Brown, 1985:176.
5. Boers M, Tugwell P, Felson DT et al. World Health Organisation and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol 1994;41(suppl.):86-9.
6. Smyth CJ, Bartholomew BA, Mills DM, Steigerwald JC, Strong SJ, Recart S. Cyclophosphamide therapy for rheumatoid arthritis. Arch Intern Med 1975;135:789-93.
7. Moreland LW, Pratt PW, Mayes MD et al. Double-blind placebo-controlled multicenter trial using chimeric monoclonal, anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. Arthritis Rheum 1995;38:1581-8.
8. Tugwell P, Pincus T, Yocum D et al. Combination with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995;333:137-41.
9. Bendix G, Bjelle A. Adding low-dose cyclosporin A to parental gold therapy in rheumatoid arthritis: a double blind placebo-controlled study. Br J Rheumatol 1996;35:1142-9.
10. Yasuda M, Sakai K, Oribe M et al. Efficacy of additive DMARD therapy in patients with rheumatoid arthritis. Double-blind controlled trial using bucillamine and placebo with maintenance doses of gold sodium thiomalate. J Rheumatol 1994;21:44-50.
11. Porter DR, Capell HA, Hunter J. Combination therapy in rheumatoid arthritis - no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy. J Rheumatol 1993;20:645-9.
12. Scott DL, Pawes PT, Tunn E et al. Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized placebo-controlled study. Br J Rheumatol 1989;28:128-33.
13. Faarvang KL, Egsmose C, Kryger P, Pødenfandt J, Ingeman-Nielsen M, Hansen TM. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial. Ann Rheum Dis 1993;32:711-4.
14. Gibson T, Emery P, Amstrong RD, Crisp AJ, Panayi GS. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis - a comparative study. Br J Rheumatol 1987;27:279-84.
15. Haar D, Sølvkjaer M, Unger B, Rasmussen KJ, Christensen L, Hansen TM. A double-blind comparative study of hydroxychloroquine and dapsone, alone and in combination, in rheumatoid arthritis. Scand J Rheumatol 1993;22:113-8.
16. Trnavsky K, Gatterová J, Lindusková M, Pelísková Z. Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis. Z Rheumatol 1993;52:292-6.
17. Ferraz MB, Pinheiro GR, Helfenstein M et al. Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A multicenter randomized placebo-controlled trial. Scand J Rheumatol 1994;23:231-6.
18. O'Dell JR, Haire CE, Erikson N et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287-91.
19. Williams HJ, Ward JR, Reading JC et al. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis, a controlled clinical trial. Arthritis Rheum 1992;35:259-69.
20. Willkens RF, Urowitz MB, Stablein DM et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1992;35:1799-806.
21. Haagsma CJ, van Riel PLCM, de Jong AJL, van de Putte LBA. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis. Br J Rheumatol 1997;36:1082-8.
22. Boers M, Verhoeven AC, Markusse HM et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.
23. van Gestel AM, Laan RFJM, Haagsma CJ, van de Putte LBA, van Riel PLCM. Oral steroids as bridge therapy in RA patients starting with parental gold. A randomized double-blind placebo-controlled trial. Br J Rheumatol 1995;34:347-51.
24. Corkill M, Kirkham BW, Chikanza IC, Gibson T, Panayi GS. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a randomised clinical trial. Br J Rheumatol 1990;29:274-9.
25. Ciconelli RM, Ferraz MB, Visioni RA, Oliveira LM, Atra E. A randomized double-blind controlled trial of sulphasalazine combined with pulses of methylprednisolone or placebo in the treatment of rheumatoid arthritis. Br J Rheumatol 1996;35:150-4.
26. Willkens RF. Comment to letter of Madhok R, and Menon N. Arthritis Rheum 1993;36:1183-4.
27. Fujii T, Suwa A, Yosida T, Mimori T, Akizuki M. Study on combinations of auranofin, salazosulfapyridine and methotrexate in rheumatoid arthritis. Ryumachi 1994;34:571-82.
28. Minami M, Kaneda K. A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA. Ryumachi 1995;35:780-91.
29. Kashiwazaki S, Akizuki M, Ichikawa Y et al. Prospective clinical study of the combination therapy of auranofin and methotrexate for rheumatoid arthritis: a multi-center study. Ryumachi 1996;36:528-44.
30. Kirwan JR, Arthritis and Rheumatism Council. Low-dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
31. Booij A, Biewenga-Booij CM, Huber-Bruning O, Cornelis C, Jacobs JW, Bijlsma JW. Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis 1996;55:811-5.
32. van den Brink HR, van Everdingen AA, van Wijk MJ, Jacobs JW, Bijlsma JW. Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis. Ann Rheum Dis 1993:52:862-5.
33. Lopez-Mendez, Daniel WW, Reading JC, Ward JR, Alarcon GS. Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic disease program randomized clinical trial of methotrexate, auranofin or a combination of the two. Arthritis Rheum 1993;36:1364-9.
34. Willkens RF, Sharp JT, Stablein D, Marks C, Wortmann R. Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment. Arthritis Rheum 1995;38:1799-806.
35. Madhok R, Menon N. Issues in the study of azathioprine, methotrexate and combination therapy: Comment on the article by Willkens et al. Arthritis Rheum 1993;36:1183-4.
36. Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995:38:727-35.
37. Haagsma CJ, van Riel PLCM, de Rooij DJRAM et al. Combination of methotrexate and sulphasalazine versus methotrexate alone. A randomised open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine alone. Br J Rheumatol 1994;33:1049-55.
38. Dougados M, Cantagrel A, Goupille P et al. Sulfasalazine, methotrexate, and the combination in early rheumatoid arthritis: a double blind randomized study. Arthritis Rheum 1996;39(suppl.):S103.
39. van der Heijde DMFM, van 't Hof MA, van Riel PLCM et al. Judging disease activity in clinical practice in rheumatoid arthritis; a first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
40. Moreland LW, Kimberley RP, Alarcon GS. European and US rheumatologists agree in triple but not on double or single early DMARD choice for different types of RA. Arthritis Rheum 1997;40(suppl.):S218.
41. O'Dell J. Combination therapy for rheumatoid arthritis: apparent universal acceptance. Arthritis Rheum 1997;40(suppl.):S119.
42. Felson DT, Anderson JJ, Meenan RF. The efficacy and toxicity of combination therapy in rheumatoid arthritis. A meta-analysis. Arthritis Rheum 1994;37:1487-91.
43. Edmonds JP, Scott DL, Furst DE, Brooks P, Paulus HE. Antirheumatic drugs: a proposed new classification. Arthritis Rheum 1993;36:336-9.